The JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY(ISSN: 1710-6222) will consider for publication original research papers (clinical or epidemiological), review articles and case reports on all aspects of clinical pharmacology and therapeutics. Editorials/Commentaries or Letters to the Editor on ethical, policy or other contemporary issues are welcomed. Authors submitting adverse event reports for publications are requested to follow the guidelines developed by Kelly et al. Adverse Event Guidelines

Manuscripts are received with the understanding that they are submitted solely to the Journal of Population Therapeutics and Clinical Pharmacology, and that none of the material contained in the manuscript has been published previously or is under consideration for publication elsewhere, excluding abstracts. The publisher reserves copyright on all published material, and material may not be reproduced without the written permission of the publisher. Statements and opinions are the responsibility of the authors.


Author Processing Charges

Please note that starting January 1, 2018 the Journal of Population Therapeutics and Pharmacology (JPTCP) will charge an Author Processing Fee (APC) of US $995, after acceptance of an article. Articles will go through a thorough peer review process, benefit from high quality editing, and will be posted on-line for greater exposure, within 60 days of acceptance. Articles are archived on the journal web site and through Portico. All articles will also be included in PubMed data base, Thompson Reuters Emerging Sources Citation Index and Scopus.



The Journal of Population Theraputics and Clinical Pharmacology is indexed with;

  • PubMed
  • Thompson Reuters Emerging Citations Index
  • Scopus
  • embase
  • CrossRef
  • Portico


For more information about the Journal of Population Theraputics and Clinical Pharmacology, please visit